Zhou S, Yao R, Zhang M, Jiang M, et al. Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study. Breast Cancer (Dove Med Press) 2026;18:589939.
PMID: 42109311